Daily Policy Digest
|Living and Deceased Organ Donation Should Be Financially Neutral Acts
Eliminating financial disincentives to donation would raise the supply of organs...
|Blood Tests Could Soon Be as Easy as a Trip to The Drugstore
A new way to conduct blood tests is transforming healthcare costs...
|Will Competition Arise for Multi-State Health Plans?
Recent regulations are unlikely to make the Multi-State Plan program a robust platform for health insurance competition...
|Healthcare and its Financial Costs to States
High healthcare costs may push states into fiscal instability...
|Caution: 21st Century Cures Act Has Suspicious Payment Plan
A new U.S. House bill could change pharmaceutical innovation forever...INVESTOR'S BUSINESS DAILY
|Do Medical Bankruptcy Laws Affect Health Insurance Rates?
High premiums on healthcare are risking bankruptcy for American taxpayers...AMERICAN ECONOMIC ASSOCIATION
|Eliminating Pharmaceutical Gray Markets
The elimination of gray markets is a perfect place to show the effect of free market initiative rather than government regulation...REAL CLEAR POLICY
|What ACA Means for Covered California
Obamacare puts California's healthcare on a road to catastrophe...
|Medicare Advantage Plans and "Upcoding"
The costliest public health insurance program in the world is getting even more costly...
|Drug Competition Means Big Savings
Price competition that drove generic drug prices down 80 to 90 percent could do the same for "biosimilar" drugs, a substitute for prohibitively expensive biologics...